Psychologists in Sunland Park, NM Accepting Medicare
5 Psychologists found. Showing 1 - 5
 Kathryn Brennan Psychologist - School Medicare: Not Enrolled in Medicare Practice Location: 4950 Mc Nutt Rd, Sunland Park, NM 88063 Phone: 505-882-6200 |
Martha Gallegos Psychologist - School Medicare: Not Enrolled in Medicare Practice Location: 4950 Mc Nutt Rd, Sunland Park, NM 88063 Phone: 505-882-6200 |
Lorena Olivas, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 3465 Mcnutt Rd, Sunland Park, NM 88063 Phone: 575-915-1338 Fax: 575-915-1819 |
 Pablo Rocha Psychologist - School Medicare: Not Enrolled in Medicare Practice Location: 4950 Mcnutt Rd, Sunland Park, NM 88046 Phone: 505-882-6200 Fax: 505-882-6280 |
Ruth Herrera Psychologist - School Medicare: Not Enrolled in Medicare Practice Location: 4950 Mc Nutt Rd, Sunland Park, NM 88063 Phone: 505-233-3915 |
News Archive
Simple interventions for Accident and Emergency patients could help reduce excessive drinking
Doctors and researchers have discovered that it is possible to reduce excessive drinking among Accident & Emergency (A&E) casualties through simple interventions such as offering appointments with alcohol health workers.
Spire Corporation awarded grant to develop nanophase calcium phosphate coatings
Spire Corporation has announced that it has been awarded an SBIR Phase I grant for $156,878 from the National Institute of Dental and Craniofacial Research, National Institutes of Health (NIH), to develop nanophase calcium phosphate coatings loaded with bone morphogenic proteins (BMPs).
Scientists to discuss latest research on spatial cognition in aging and neurodegeneration
Scientists from Germany and abroad will be meeting in Magdeburg from 27 to 29 November 2018 to discuss latest research on spatial cognition in aging and neurodegeneration. The symposium is hosted by the German Center for Neurodegenerative Diseases.
Lotus receives Chinese SFDA approval for R-Bambuterol Hydrochloride Phase I human clinical trials
Lotus Pharmaceuticals, Inc., a fast-growing, profitable developer, manufacturer and seller of medicine and drugs in the People's Republic of China ("PRC"), announced today that it received approval from the State Food and Drug Administration ("SFDA") Ethics Committee to commence Phase I human clinical trials of R-Bambuterol Hydrochloride, the Company's proprietary drug candidate for the treatment of asthma.
› Verified 1 days ago